Quick Answer
STANDARD BIOTOOLS INC. reported R&D Expense of $25.99 million for fiscal year 2025.
STANDARD BIOTOOLS INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $25.99M | -9.9% |
| 2024 | $28.83M | +11.1% |
| 2023 | $25.95M | -30.6% |
| 2022 | $37.38M | -1.5% |
| 2021 | $37.94M | +4.1% |
| 2020 | $36.46M | +15.2% |
| 2019 | $31.64M | +5.4% |
| 2018 | $30.03M | -2.6% |
| 2017 | $30.83M | -19.8% |
| 2016 | $38.41M | -2.2% |
| 2015 | $39.26M | -9.6% |
| 2014 | $43.42M | +117.6% |
| 2013 | $19.95M | +20.2% |
| 2012 | $16.60M | +19.1% |
| 2011 | $13.94M | +7.1% |
| 2010 | $13.01M | +5.6% |
| 2009 | $12.31M | +49160.0% |
| 2003 | $25.0K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.36M | -8.4% | +2.2% |
| June 30, 2025 | $6.22M | -14.1% | -45.1% |
| March 31, 2025 | $11.33M | -29.1% | +63.3% |
| September 30, 2024 | $6.94M | +8.9% | -4.2% |
| June 30, 2024 | $7.24M | +17.1% | -54.7% |
| March 31, 2024 | $15.98M | +148.6% | +150.9% |
| September 30, 2023 | $6.37M | -24.9% | +3.0% |
| June 30, 2023 | $6.18M | -50.9% | -3.8% |
- STANDARD BIOTOOLS INC. showed a decrease of -9.9% in R&D Expense compared to the prior fiscal year.
- Over the 2003–2025 period, STANDARD BIOTOOLS INC.’s r&d expense has grown by 103848.0% (from $25.0 thousand to $25.99 million).
- The most recent figure is from STANDARD BIOTOOLS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: